Medical Marijuana info

Giving Tuesday is the largest global giving day all year and NORML is excited to be a part of this worldwide event! We’ve set a goal to raise $10,000. It’ll take everyone to get it done, but the impact your donations will have is going to be incredible. Year-end giving helps NORML ...

Adult-use retail cannabis access is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to data published in the journal Complimentary Therapies in Medicine. Investigators from the University of New Mexico and California Polytechnic State University assessed trends in the demand for OTC sleep aids in ...

Licensed storefronts are now eligible to engage in retail cannabis sales to adults. The first adult-use sales began on Sunday, December 1. Michigan voters last year approved a statewide initiative authorizing state officials to regulate the plant’s production, use, and sale. In October, state regulators began accepting applications from medical cannabis dispensaries ...

At NORML, as we gather around the table today, we’re thankful not only for the dozens of legislative victories and the historic votes in Congress in 2019, we’re thankful for you, our supporters, members, and donors, who’ve made this progress possible. It’s because of your passion, commitment, and generosity that ...

Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury). Minnesota investigators identified the presence ...

The occasional use of cannabis during late adolescence is not independently associated with adverse effects on cognitive abilities in young adulthood, according to longitudinal data published in the journal Drug and Alcohol Dependence. A team of investigators affiliated with the University of Colorado at Boulder assessed the impact of cannabis ...

Representatives of the US Food and Drug Administration issued warning letters on Monday to multiple companies for marketing CBD-specific products in ways that violate federal law. The agency issued warning letters to 15 commercial entities. Seven additional companies received similar letters earlier this year. The FDA alleges that the companies marketed ...

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. A team of investigators from Canada and the United States assessed drug use trends in chronic pain patients over a multi-year period ...

For the first time ever, a congressional committee has approved a piece of legislation to end marijuana prohibition in the United States. The Marijuana Opportunity, Reinvestment, and Expungement Act, better known as The MORE Act, would remove marijuana from the Controlled Substances Act and impose a minor excise tax on ...

Today, you were a part of making history. The House Judiciary Committee just approved the MORE Act on a bipartisan vote of 24-10.  This is legislation that tens-of-thousands advocated for by sending messages, making phone calls, and meeting with lawmakers in DC and district offices. This marks the first time that ...